28 results
8-K
EX-10.1
IMPL
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
in cash (or through offset against other cash Taxes payable).
ARTICLE 8.
CONDITIONS PRECEDENT
8.1 Conditions to Each Party’s Obligation
424B5
IMPL
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
forward to offset future taxable income, if any, until such unused losses expire. Under the Tax Reform Act, as modified by the Coronavirus Aid, Relief … net operating loss carryforwards and other pre-change tax attributes (such as research tax credits) to offset our post-change income or taxes may
8-K
EX-10.1
IMPL
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
, offset, claim or counterclaim by or in favor of Landlord against Tenant under the Lease or against the obligations of Landlord under the Lease
PRE 14A
5vc 22fxk8v5hdlj
14 Apr 23
Preliminary proxy
4:11pm
8-K
EX-99.1
vbv1p 8p79vbb4i3rml
14 Nov 22
Impel PHARMACEUTICALS Announces THIRD Quarter 2022 Financial Results and Provides CORPORATE Update
7:55am
8-K
EX-99.1
vvv2 r1c252d
15 Aug 22
Impel PHARMACEUTICALS Announces SECOND Quarter 2022 Financial Results and Provides CORPORATE Update
8:06am
DEF 14A
98leywy
26 Apr 22
Definitive proxy
4:16pm
10-K
q3ykzxsskygr
29 Mar 22
Annual report
5:09pm
424B4
jeld 7gr3w0bdb
10 Sep 21
Prospectus supplement with pricing info
4:01pm